Septerna Announces Novel GPCR-targeted Program Acquired by Vertex
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 508.75 +10.25 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $498.50 | 52 Week High | $134.71 | |||
| Open | $514.91 | 52 Week Low | $73.31 | |||
| Day High | $517.68 | P/E | N/A | |||
| Day Low | $507.21 | EPS | $-1.98 | |||
| Volume | 2,262,550 | |||||
